Elevance Health Inc. Stock Underperforms Friday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.Elevance Health Inc. (ELV) shares fell 1.17% to $394.43 on Friday, underperforming the broader market and several competitors. This marks the stock's second consecutive day of losses, with ELV trading 9.58% below its 52-week high. While UnitedHealth Group and Humana also declined, Cigna Group rose slightly. The drop occurred during a generally weak trading session where the S&P 500 and Dow Jones Industrial Average also posted minor declines.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Elevance Health Inc. (ELV) slipped 1.17% to $394.43 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.25% to 7,711.76 and Dow Jones Industrial Average falling 0.02% to 53,559.99.
This was the stock's second consecutive day of losses.
Elevance Health Inc. closed 9.58% below its 52-week high of $436.24, which the company reached on July 14th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as UnitedHealth Group Inc. (UNH) fell 0.53% to $392.95, Cigna Group (CI) rose 0.44% to $278.88, and Humana Inc. (HUM) fell 1.81% to $385.54.
Data source: Dow Jones Market Data, FactSet. Data compiled August 28, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-28-26 1642ET